111 related articles for article (PubMed ID: 3893490)
1. Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure.
Shaw TR; Duncan FM; Williams BC; Crichton E; Thomson SA; Davis JR; Rademaker M; Edwards CR
Br Heart J; 1985 Aug; 54(2):160-5. PubMed ID: 3893490
[TBL] [Abstract][Full Text] [Related]
2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
6. Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
Cody RJ; Covit A; Schaer G; Williams G
Am Heart J; 1982 Nov; 104(5 Pt 2):1180-3. PubMed ID: 6291363
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of captopril in patients with severe chronic heart failure.
LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
[TBL] [Abstract][Full Text] [Related]
9. Intravenous captopril treatment in patients with severe cardiac failure.
Rademaker M; Shaw TR; Williams BC; Duncan FM; Corrie J; Eglen A; Edwards CR
Br Heart J; 1986 Feb; 55(2):187-90. PubMed ID: 3510643
[TBL] [Abstract][Full Text] [Related]
10. [Acute and long-term effect of captopril in severe chronic heart failure].
Kikis D; Heck I; Stumpe KO; Esser H
Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
[TBL] [Abstract][Full Text] [Related]
11. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Silberbauer K; Punzengruber C; Sinzinger H
Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
[TBL] [Abstract][Full Text] [Related]
12. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
13. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Levine TB; Franciosa JA; Cohn JN
Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
[No Abstract] [Full Text] [Related]
14. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
Cleland J; Semple P; Hodsman P; Ball S; Ford I; Dargie H
Am J Med; 1984 Nov; 77(5):880-6. PubMed ID: 6388325
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
Packer M; Medina N; Yushak M; Meller J
Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
Packer M; Medina N; Yushak M; Lee WH
Br Heart J; 1985 Sep; 54(3):298-304. PubMed ID: 2994697
[TBL] [Abstract][Full Text] [Related]
18. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
[TBL] [Abstract][Full Text] [Related]
19. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
Sharpe DN; Coxon RJ
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
[TBL] [Abstract][Full Text] [Related]
20. [Long-term treatment of severe cardiac failure with captopril (author's transl)].
Komajda M; Eugène M; Evans J; Lecossier D; Grosgogeat Y
Nouv Presse Med; 1981 Apr; 10(19):1587-90. PubMed ID: 7025850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
